© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#tenofovir disoproxil fumarate

FDA Approved stamp
FDA Approves Three New, Cheaper Combination ARV Tablets
Tenofovir Disoproxil Fumarate 101
Chart of Approved and Experimental HIV Medications
Descovy and Truvada

Truvada Should Remain First Choice for PrEP, Experts Argue

Both Truvada and Descovy are highly effective and safe for most people taking PrEP, but the newer option has more cost barriers.

What’s the Skinny on Bone Health for People With HIV?

Researchers have called for revised treatment guidelines to address the higher risk of fracture in the HIV population.
Descovy and Truvada

TAF Versus TDF: What’s the Difference?

Descovy and Truvada

What’s the difference between Truvada and Descovy for PrEP?

Learn about the differences between these two HIV prevention options.

Why Do Some Newer HIV Drugs Cause Weight Gain?

Future research should examine how particular combinations of antiretrovirals contribute to weight gain, according to one expert.

Switching to New Tenofovir Tied to Improved Bone Health in Older People With HIV

Participants entered the study taking tenofovir disoproxil fumarate, and some were switched to a regimen including tenofovir alafenamide.

Biktarvy Maintains High Efficacy for Three Years in Clinical Trials

The integrase inhibitor–based HIV regimen was compared with dolutegravir-based regimens.

Switching to Descovy for PrEP Improves Kidney and Bone Biomarkers

However, serious kidney problems and bone fractures were rare among people taking either Descovy or Truvada for HIV prevention.

Switching to New Tenofovir Linked to Rise in BMI and Cardiovascular Risk

This finding from a study of people switching from TDF to TAF for HIV treatment may also have implications for those on PrEP.

Switching Back to Older Tenofovir Improves Lipid Levels

The newer tenofovir formulation can raise cholesterol and triglyceride levels, but these changes are reversible.

The International AIDS Society Conference’s Most Vital Findings

A roundup of POZ’s reporting on studies presented at the Mexico City conference about HIV treatment, vaccines, PrEP and other concerns.

Only Subnormal Kidney Function May Get Boost From Switch to New Tenofovir

Swiss researchers analyzed shifts in kidney function among those switching from the old form of the HIV medication to the new one.
Tivicay

Tivicay Plus Truvada or Descovy Is as Effective as Atripla at Treating HIV

However, Tivicay plus Descovy was associated with greater weight gain, especially among women.

Many Heavily Treated People With HIV Do Not Need NRTIs

Long-term salvage therapy without NRTIs suppressed HIV in nearly 80% of those who remained in care.
Descovy, which contains TAF, the updated version of tenofovir, along with emtricitabine.

Analysis Backs New Tenofovir’s Kidney Safety Over Old Version

Researchers compared data on more than 9,000 people with HIV who took either version of tenofovir.

AIDS Activists File Antitrust Lawsuit Against HIV Drug Manufacturers

Pharma giants made agreements to keep prices high and block competition for generics, the civil lawsuit alleges.
Advertisement
Treatment News
Newsfeed